SCHEMBL19082136

SCHEMBL19082136

c1ccc2cc(-c3c4ccccc4c(-c4cc5c6ccc7ccccc7c6sc5c5sc6ccccc6c45)c4ccccc34)ccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.36
CYP1A1 P04798 6/20 0.34
CYP1B1 Q16678 6/20 0.34
CYP1A2 P05177 3/20 0.34
ALOX5 P09917 1/20 0.34
NQO1 P15559 1/20 0.32
NQO2 P16083 1/20 0.32
S1PR4 O95977 4/20 0.32
S1PR5 Q9H228 4/20 0.32
MAPT P10636 1/20 0.31
PTPRC P08575 1/20 0.31
PTPRF P10586 1/20 0.31
PTPRA P18433 1/20 0.31
PTPRB P23467 1/20 0.31
PTPN6 P29350 1/20 0.31
DUSP3 P51452 1/20 0.31
PTPN12 Q05209 1/20 0.31
MAPK9 P45984 1/20 0.31
MAPK14 Q16539 1/20 0.31
GSTP1 P09211 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082207 0.94 CYP1A1 (0.38) PTPN1CYP1A1CYP1B1CYP1A2ALOX5
SCHEMBL19082296 0.94 PTPN1 (0.36) PTPN1CYP1A1CYP1B1CYP1A2ALOX5
SCHEMBL17932070 0.92 PTPN1 (0.40) PTPN1ALOX5NQO1NQO2S1PR4
SCHEMBL19082421 0.87 PRKDC (0.34) PTPN1CYP1A1CYP1B1CYP1A2ALOX5
SCHEMBL17944206 0.87 ALOX5 (0.37) PTPN1ALOX5S1PR4S1PR5MAPT
SCHEMBL19077471 0.87 ALOX5 (0.43) CYP1A1CYP1B1CYP1A2ALOX5S1PR4
SCHEMBL19077454 0.86 ALOX5 (0.38) PTPN1CYP1A1CYP1B1CYP1A2ALOX5
SCHEMBL17944211 0.85 PTPN1 (0.39) PTPN1ALOX5NQO1NQO2S1PR4
SCHEMBL19077350 0.85 ALOX5 (0.39) PTPN1CYP1A1CYP1B1CYP1A2ALOX5
SCHEMBL19082271 0.85 CYP1A1 (0.38) PTPN1CYP1A1CYP1B1CYP1A2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PTPN1 4695/4885CYP1A1 184/4885CYP1B1 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.